Autosomal dominant polycystic kidney disease (ADPKD) causes a lot of fluid-filled sacs, called cysts, to grow in your kidneys. The cysts keep your kidneys from working as they should.

Dubai, United Arab Emirates;July 2025 - The traditional way to treat people with advanced kidney disease has been to use ...

People with autosomal dominant polycystic kidney disease (ADPKD) are at a high risk of developing kidney failure during their lives. Although there are many strategies that can be used to help ...

Bhatt was just 26 when she was diagnosed with polycystic kidney disease (PKD)—a condition she discovered by chance while ...

Autosomal dominant polycystic kidney disease (ADPKD), the most common hereditary kidney disorder, is characterized by the development and expansion of multiple cysts scattered throughout the ...

Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the unrelenting enlargement of innumerable cysts derived from renal tubules. This cystic growth often leads to a grotesque ...

ADPKD is a common inherited form of kidney disease. It is caused by flaws in specific genes (PKD1 or PKD2), leading to numerous cysts growing in the kidneys, which can eventually cause kidney failure.

The 2025 KDIGO guideline is the first specifically addressing autosomal dominant polycystic kidney disease (ADPKD) and focuses on some unique aspects of management.

Rees said following the foundation of the APKD, they began to take those who had incompatible pairs for kidney or liver donation and match them with another person.

The Alliance for Paired Kidney Donation (APKD), a global leader in paired kidney donation, and transplant software company MedSleuth announced today a U.S. partnership launched to increase access ...

Farabursen is being developed as a treatment for autosomal dominant polycystic kidney disease (ADPKD). This rare disease leads to the development of cysts in organs, mainly the kidneys.